Chenghui Yang, Yiying Xu, Ouchen Wang. "Inetetamab combined with pyrotinib for neoadjuvant treatment of HER2-positive locally advanced breast cancer (neoPICD): A prospective, multicenter, single-arm phase II trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.27